Advanced search
Publication Cover
Infectious Diseases Volume 48, 2016 - Issue 11-12
Submit an article Journal homepage
152
Views
8
CrossRef citations to date
0
Altmetric
Letter to the Editor

Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Felipe Francisco TuonDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; Correspondence[email protected]
,
Bruna Zanette de AragaoDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;
,
Thiago Almeida SantosDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;
,
Juliano GasparettoDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;
,
Kassia CordovaDepartment of Medicine, Faculdade Evangélica do Paraná, Curitiba, Brazil
&
Marcela AbujamraDepartment of Medicine, Faculdade Evangélica do Paraná, Curitiba, Brazil
Pages 869-871 | Received 05 Jun 2016, Accepted 13 Jun 2016, Published online: 08 Jul 2016

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jiaxin Yu, Wei Zuo, Hongwei Fan, Jiayu Wu, Luyao Qiao, Benyu Yang, Wenxi Li, Yang Yang & Bo Zhang. (2023) Ceftazidime-Avibactam for Carbapenem-Resistant Gram-Negative Bacteria Infections: A Real-World Experience in the ICU. Infection and Drug Resistance 16, pages 6209-6216.
Read now
Juan Chen, Qiqiang Liang, Xinyi Chen, Jing Wu, Yanchao Wu, Gaoqin Teng & Man Huang. (2022) Ceftazidime/Avibactam versus Polymyxin B in the Challenge of Carbapenem-Resistant Pseudomonas aeruginosa Infection. Infection and Drug Resistance 15, pages 655-667.
Read now
Carmen Antonia Sanches Ito, Larissa Bail, Lavinia Nery Villa Stangler Arend, Keite da Silva Nogueira & Felipe Francisco Tuon. (2021) The activity of ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa. Infectious Diseases 53:5, pages 386-389.
Read now

Articles from other publishers (5)

Yanfeng Liu, Ya Liu, Yi Liu, Xuefeng Chen & Yan Jia. (2023) Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation. Heliyon 9:4, pages e15285.
Crossref
Felipe Francisco Tuon, Leticia Ramos Dantas, Paula Hansen Suss & Victoria Stadler Tasca Ribeiro. (2022) Pathogenesis of the Pseudomonas aeruginosa Biofilm: A Review. Pathogens 11:3, pages 300.
Crossref
Ekaterina V. Eliseeva, Ilya Sulejmanovich Azyzov & N.A. Zubareva. (2019) Review of the international consensus guidelines for the optimal use of the polymyxins. Clinical Microbiology and Antimicrobial Chemotherapy 21:4, pages 282-309.
Crossref
Brian T. Tsuji, Jason M. Pogue, Alexandre P. Zavascki, Mical Paul, George L. Daikos, Alan Forrest, Daniele R. Giacobbe, Claudio Viscoli, Helen Giamarellou, Ilias Karaiskos, Donald Kaye, Johan W. Mouton, Vincent H. Tam, Visanu Thamlikitkul, Richard G. Wunderink, Jian Li, Roger L. Nation & Keith S. Kaye. (2019) International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:1, pages 10-39.
Crossref
Emily C. Tucker, Matthew B. Roberts & David L. Gordon. 2017. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 229 243 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.